尽管存在持续风险,但2025年11月30日,七个与中国相关的股票的交易量因交易活动而大幅增加. Seven Chinese-linked stocks surged in volume on Nov. 30, 2025, due to trading activity, despite ongoing risks.

据MarketBeat报道,在2025年11月30日,中国七家股票的交易量升,包括UP Fintech,Baiya International,Regencell Bioscience,RBB Bancorp,中国SXT制药,HF Foods和Diageo. Seven Chinese stocks—UP Fintech, Baiya International, Regencell Bioscience, RBB Bancorp, China SXT Pharmaceuticals, HF Foods, and Diageo—spiked in trading volume on November 30, 2025, according to MarketBeat. 这些公司横跨芬兰科技、生物技术、银行、制药和食品分销等行业,在中国开展业务或为亚裔美洲社区提供服务。 The companies span fintech, biotech, banking, pharmaceuticals, and food distribution, with operations in China or serving Asian-American communities. 它们通过ADRs或GDRs列出,暴露在中国经济中,但具有监管、治理、货币变动和地缘政治的风险。 Listed via ADRs or GDRs, they offer exposure to China’s economy but carry risks from regulation, governance, currency shifts, and geopolitics.